Steve Schonfeld’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$797K Buy
+36,549
New +$1.07M ﹤0.01% 1746
2026
Q1
– Sell
-8,932
Closed -$414K – 2294
2025
Q4
$414K Buy
+8,932
New +$374K ﹤0.01% 1466
2022
Q4
– Sell
-18,000
Closed -$289K – 2648
2022
Q3
$289K Buy
+18,000
New +$317K ﹤0.01% 2109
2019
Q1
– Sell
-130,800
Closed -$2.25M – 1075
2018
Q4
$2.25M Sell
130,800
-75,000
-36% -$1.28M 0.09% 299
2018
Q3
$3.03M Buy
+205,800
New +$3.65M 0.13% 209
2017
Q3
– Sell
-42,931
Closed -$537K – 623
2017
Q2
$537K Buy
42,931
+25,425
+145% +$251K 0.06% 378
2017
Q1
$176K Buy
+17,506
New +$260K 0.02% 554

Other funds holding COLL

Steve Schonfeld's COLL Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 36,549 shares worth $797K. The stake represents ﹤0.01% of the portfolio and ranks #1746 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in COLL as recently as Q4 2025.

Steve Schonfeld first reported a position in COLL in Q1 2017 and has held it in 7 quarters since. The position peaked at $3.03M in Q3 2018. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Steve Schonfeld held 36,549 shares of Collegium Pharmaceutical worth $797K as of Q3 2026.
  • Collegium Pharmaceutical was a new Steve Schonfeld position in Q3 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1746 holding.
  • Steve Schonfeld first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 7 quarters since.
  • Steve Schonfeld's Collegium Pharmaceutical position peaked at $3.03M in Q3 2018.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.